AI assistant
Biocon Ltd. — Capital/Financing Update 2025
Apr 20, 2025
61176_rns_2025-04-20_8f97d69d-dab3-4b1c-b222-9751824219d1.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [125 x 50] intentionally omitted <==
Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T: 91 80 2808 2808 F: 91 80 2852 3423
CIN : L24234KA1978PLC003417
BIO/SECL/TG/2025-26/13
April 20, 2025
To, To, The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 050 Scrip Code – 532523 Scrip Symbol - Biocon
Dear Sir/Madam,
Subject: Intimation for the Board Meeting pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, April 23, 2025, inter alia, to consider and approve the proposal for raising of funds by way of issue of equity shares or any other eligible securities, through one or more of the permissible modes including but not limited to qualified institutions placement, rights issue, preferential issue, further public offer, etc., subject to requisite approvals under the applicable laws, including approval of shareholders of the Company, as may be required, in this regard.
The above-mentioned information will also be available on the website of the Company at www.biocon.com.
Kindly take the above information on record and acknowledge.
Thanking You,
For Biocon Limited
Digitally signed by SIDDHART SIDDHARTH MITTAL H MITTAL Date: 2025.04.20 14:11:01 +05'30' _______________
Siddharth Mittal Managing Director & CEO DIN: 03230757